Biogen's total assets 2014-2023
This statistic shows the total assets of Biogen from 2014 to 2023, in million U.S. dollars. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. According to the company, assets increased from 14.3 billion U.S. dollars in 2014 to 27.2 billion U.S. dollars in 2019, the highest amount in the provided period.